Catalyst Wire Dossier Catalyst Wire Dossier

Levofloxacin (ophthalmic)

levofloxacin · Santen Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levofloxacin (ophthalmic), covering 2009-02-06 to 2009-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators [Phase 4]

See pricing